Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
February 2010
 Dentsply reported 4Q:09 sales of $568.7 million, up 12% over the year-ago period and beating estimates by $12.0 million. Chairman and CEO Bret Wise commented, "We are pleased to report stronger sales and earnings for the fourth quarter, as we are beginning to see the initial signs of recovery in select markets and regions." more
 Alphatec Spine reported 4Q:09 revenues of $36.6 million, an increase of 29% from the $28.4 million reported in 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. Asian revenues were $6.6 million, an increase of 38% from the $4.8 million reported for 4Q:08. European revenues in 4Q:09 were $1.7 million. more
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine,... more
On Tuesday Nobel Biocare announced that it would expand its Preferred Partner Program to include Noritake Dental Supply. The company says the partnership "enables Nobel Biocare to offer superior end-to-end prosthetic solutions." Based in Nagoya, Japan, Noritake Dental specializes in... more
Despite the increased mobility associated with total knee replacement, a new study found that TKA patients actually gain more weight post-operatively than non-surgical controls. The study, published in Osteoarthritis and Cartilage, enrolled 106 TKA patients and 31 non-surgical controls. The... more
This morning President Obama announced his plan for reforming healthcare. The proposal is similar to the legislation the Senate passed late last year, though it includes some concessions to the House, and the president describes it as "[bridging] the gap"... more
Yesterday the FDA hosted an all-day public hearing to gain feedback on its 510(k) process, looking specifically at issues of predicate devices, new technologies, submission volume and post-market surveillance. The event was webcast and opened to a packed house -... more
Earnings DJO reported 4Q:09 revenues of $257.2 million, up 5% over 4Q:08, with domestic rehab sales up 3% and domestic surgical implant sales up 8%. The company attributed the latter largely to "strong sales of our Reverse Shoulder Prosthesis." Net... more
Blue Cross and Blue Shield announced that they would broaden their "Blue Distinction" designation granted to high-performing hospitals to include spine and hip and knee centers. Blue Distinction hospitals have met objective, "evidence-based thresholds for clinical quality and safety" and... more
The FDA approved a BLA for Auxilium's Xiaflex (collagenase clostridium histolyticum) last week, following a unanimous panel recommendation (registration required) in September. Xiaflex is the first non-surgical treatment for Dupuytren's Contracture, which is characterized by a bending of the fingers... more
Earnings Nobel Biocare reported 4Q:09 revenues of EUR 156.0 million ($213.6 million), flat over the year-ago period and missing estimates by EUR 5.0 million ($6.9 million.) EPS of EUR 0.21 ($0.29) missed estimates by EUR 0.05 ($0.07). The company called... more
As outlined in President Obama's proposed budget for the 2011 fiscal year, the FDA has increased their operating budget for the upcoming year by about 23% to $4 billion. The agency has said the bulk of the increase will be... more
Starting in October 2009, HealthpointCapital initiated a one-year Research Scholarship at the Hospital for Special Surgery (HSS) for a select oprthopedic surgeon from China. This month, we checked in with our Research Scholar, Dr. Xiaodong Ju, to see how he... more
Earnings CONMED reported 4Q:09 sales of $190.6 million, up 3% over the year-ago period and beating estimates by $6.0 million. Arthroscopy sales rose 3% to $75.7 million. All growth rates exclude the effects of currency. 4Q:09 EPS of $0.37 beat... more
Despite some prior indications that the 510(k) process would remain as-is for now, it seems 510(k) reform is now taking a prominent spot on the FDA's agenda for 2010, with one report saying "revisions" to the pathway should be in... more
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine,... more
Last Friday, NuVasive pre-announced full-year 2009 revenues of $370 million, increasing about 48% over 2008, and EPS of $0.14-$0.15. Analysts had forecast sales of $367 million and EPS of $0.14, setting the company up for a modest top-line beat. President... more
Complete Archive
|
